Page last updated: 2024-10-30

ketotifen and Fibroma

ketotifen has been researched along with Fibroma in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Fibroma: A benign tumor of fibrous or fully developed connective tissue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klepper, L1
Tronnier, M1

Other Studies

1 other study available for ketotifen and Fibroma

ArticleYear
[Multiple fibromas in systemic mastocytosis].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:5

    Topics: Aged; Antidepressive Agents, Tricyclic; Antipruritics; Biopsy; Fibroma; Histocytochemistry; Humans;

2005